Yang (Claire) Zeng

Claire has extensive research experience and pioneered the therapeutic platform in Shih lab. She published her cancer vaccine work in Nature Nanotechnology and is currently leading a team with several more manuscripts in preparation. Now transitioning to entrepreneurship, she is spinning off a company called DoriNano to translate her prior work into commercial applications.